Homeopathic medicines for treatment of high blood sugar

Phase 2

Completed

• Conditions: Health Condition 1: R739- Hyperglycemia, unspecified

• Registration Number: CTRI/2022/04/042026
• Lead Sponsor: D N De Homoeopathic Medical College and Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2023-07-03
• Last Update Posted: 18 September 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

1. Patients having pre-diabetes: HbA1c 5.7-6.4%,

fasting blood glucose 100-125 mg/dl, impaired

fasting glucose- 140-199 mg/dl (ICD-10 code

R73.09).

2. Age: 18-65 years.

3. Sex: Both Male and Female.

4. Indian Diabetic Risk Score (IDRS) more than 60.

5. Literate patient; ability to read English or

Bengali

6. Providing with written informed consent

Exclusion Criteria

1. Patients having diabetes mellitus.

2. Currently undergoing anti-diabetic drug

therapy

3. Diagnosed cases of unstable mental or

psychiatric illness or other uncontrolled or

life-threatening illness affecting quality of

life or any vital organ failure.

4. Patients with a habit of tobacco chewing and/

or smoking, alcoholism and/or any other

form(s) of substance abuse and/or dependence.

5. Vulnerable population: unconscious,ambulatory,

too sick for consultation, differently abled,

terminally or critically ill patients,

mentally incompetent people.

6. Self-reported immune-compromised state.

7. Dyslipidemia: Total cholesterol- more than

199 mg/dl of blood, triglycerides more than

150 mg/dl, LDL more than 100 mg/dl, VLDL more

than 150 mg/dl.

8. Serum urea: more than 40 mg/dl of blood and

serum creatinine more than 1.2 mg/dl of blood

will be excluded.

9. Pregnant and puerperal women and lactating

mothers.

10. Undergoing homeopathic treatment for any

chronic disease within last 6 months.

11. Patients who are too sick for consultation.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The proportion of pre-diabetics converting into diabeticsTimepoint: After 3 months and 6 months

Secondary Outcome Measures

Name	Time	Method
Fasting blood sugar, oral glucose tolerance test, HbA1C%, lipid profile, serum urea, creatinine, liver enzymes (ALT, AST)Timepoint: At baseline, after 3 months & 6 months;Measure Yourself Medical Outcome Profile 2 (MYMOP2) questionnaireTimepoint: At baseline, and after 3 months and 6 months